• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Accent Microcell Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 92465.0
  • ISIN : INE0Q5D01013
311.95 -4 (-1.27%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    309.00

  • Today’s High

    320.00

  • Open

    312.50

  • Perv Close

    315.95

  • 52W Low

    170.26

  • 52W High

    324.00

Key Indicators

  • P/E(TTM)

    22.64

  • Mar.Cap (₹Cr.)

    748.34

  • Div & Yield %

    0.32

  • Book Value(₹)

    97.78

  • Debt-Equity Ratio

    -1.27

  • AGM Date

    01-Aug-2025

  • EPS

    13.78

  • P/E Ratio

    22.64

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    748.34

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.99

  • BV (₹)

    97.80

  • Sales( ₹ in Cr.)

    264.58

  • NP (in Cr.)

    33.06

  • NP Var(%)

    7.0

  • Div%

    0.0

  • CPS (₹)

    15.50

  • EPS (₹)

    13.80

  • Traded Value (₹ in Lakhs)

    748.34

  • 52 Week High

    324.00

  • 52 Week Low

    170.26

  • Price BSE

    0.0

  • Price NSE

    312.00

  • Market Capital( in Cr.)

    748.34

  • P/C Ratio

    20.10

  • P/E Ratio

    22.60

  • Price Vs.BV

    13.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 245.50 197.27 165.71 132.57 131.38 113.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 245.50 197.27 165.71 132.57 131.38 113.99
Other Income 3.63 2.49 1.83 2.25 3.99 5.54
Stock Adjustments -14.62 9.71 6.94 8.94 3.61 0.22
Total Income 234.51 209.47 174.48 143.76 138.98 119.75
EXPENDITURE :            
Raw Materials 131.31 129.19 120.28 99.05 88.69 76.06
Power and Fuel Cost 22.71 23.26 3.34 3.16 4.87 4.37
Employee Cost 11.03 8.97 7.62 6.93 9.42 7.53
Other Manufacturing Expenses 11.26 9.63 9.94 9.85 10.49 10.74
Selling and Administration Expenses 12.83 16.54 17.51 10.65 12.53 9.65
Miscellaneous Expenses 3.27 0.45 0.98 1.18 0.20 0.22
Employee Benefit Expenses 11.03 8.97 7.62 6.93 9.42 7.53
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 192.40 188.03 159.67 130.82 126.21 108.58
Operating Profit 42.11 21.44 14.81 12.94 12.77 11.17
Interest 1.15 2.53 3.07 3.38 3.41 3.17
Gross Profit 40.96 18.91 11.74 9.56 9.36 8.00
Depreciation 4.43 4.11 4.15 3.55 3.30 3.24
Profit Before Tax 36.53 14.80 7.59 6.01 6.06 4.76
Current Tax 6.39 2.59 1.66 1.19 1.01 1.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 -0.02 0.04 0.01 0.87 0.13
Reported Net Profit 30.17 12.23 5.89 4.80 4.18 3.62
Extraordinary Items -0.83 0.00 0.00 -0.22 0.00 0.00
Adjusted Net Profit 31.00 12.23 5.89 5.02 4.18 3.62
Adjustment below Net Profit 0.00 0.00 0.00 -3.27 0.00 0.00
P & L Balance brought forward 36.62 24.38 12.95 11.42 7.24 3.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.04 0.00 0.43 0.00 0.00 0.00
P & L Balance carried down 65.75 36.62 18.41 12.95 11.42 7.24
Dividend 1.04 0.00 0.43 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 8.00 8.00 10.00 0.00 0.00
Dividend Per Share(Rs) 1.00 0.80 0.80 1.00 0.00 0.00
Earnings Per Share-Unit Curr 14.34 9.45 4.57 11.17 9.71 8.42
Earnings Per Share(Adj)-Unit Curr 13.56 - - - - -
Book Value 77.86 38.96 24.87 61.92 58.36 48.64
Book Value(Adj)-Unit Curr 73.65 - - - - -

Shareholding Pattern

  • Promoter Group

    55.47%

  • Public Share Holding

    44.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 13,305,840 55.47 13,305,840 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,305,840 55.47 13,305,840 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,500 0.01 2,500 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 696,160 2.90 696,160 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 698,660 2.91 698,660 5
2] Non Institution
Bodies Corporate 557,680 2.32 557,680 71
Clearing Members 420 0.00 420 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 179,210 0.75 179,210 88
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 665,780 2.78 665,780 203
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,643,720 19.36 4,643,720 46
Individuals holding nominal share capital up to Rs. 1 lakh 3,933,580 16.40 3,933,580 2,634
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,130 0.02 4,130 2
Others 0 0.00 0 0
Sub Total 9,984,520 41.62 9,984,520 3,045
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,989,020 100.00 23,989,020 3,066

Company Background

Accent Microcell LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Accent Microcell Ltd
  • BSE Code : 92465.0
  • ISIN : INE0Q5D01013

  • Incorporation Year

    2012

  • Registered Office

    314 Shangrilla Arcade Shyamal-
    Crs.Rd Anandnagar Rd Satellite, Ahmedabad,
    Gujarat-380015

  • Telephone

    +91 75758 03351

  • FAX

  • Chairman

    Vasant Vadilal Patel

  • Managing Director

    Ghanshyam Arjanbhai Patel

  • Company Secretary

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Accent Microcell Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Accent Microcell 311.95 249.13 245.50 22.64 30.04
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10